logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Jounce Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 11

% Expired Patents = 9.1


Trademarks = 2

Forward Citations = 17

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Stephen Sazinsky (6 out of 6 patents)

silverMedal Sriram Sathyanarayanan (4 out of 10 patents)

bronzeMedal George Robert Mabry, Iii (3 out of 3 patents)

4.  Kutlu Goksu Elpek (3 out of 6 patents)

5.  Jennifer S Michaelson (3 out of 5 patents)

6.  Heather B Cohen (2 out of 2 patents)

7.  Lauren Pepper Mackenzie (2 out of 2 patents)

8.  Donald Raymond Shaffer (2 out of 5 patents)

9.  Jeffrey Yan-Fei Smith (2 out of 2 patents)

10.  Christopher Harvey (2 out of 8 patents)

11.  Heather Hirsch (1 out of 2 patents)

12.  Deborah Law (1 out of 1 patent)

13.  Amanda Elizabeth Hanson (1 out of 1 patent)

14.  Martin Yu Fan (1 out of 1 patent)

15.  Tatiana Novobrantseva (1 out of 30 patents)


11 patents:

1. 12729241 - ANTIBODIES THAT BIND TO HUMAN CHEMOKINE (C-C MOTIF) RECEPTOR 8 (CCR8) (2026-09-08),
2. 11905329 - Anti-PD-1 antibodies and uses thereof (2024-02-20),
3. 11384147 - Anti-PD-1 antibodies and uses thereof (2022-07-12),
4. 11359019 - Antibodies to LILRB2 (2022-06-14),
5. 11292840 - Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist (2022-04-05),
6. 10968277 - Gene signatures for determining ICOS expression (2021-04-06),
7. 10723798 - Antibodies to LILRB2 (2020-07-28),
8. 10654929 - Antibodies to PD-1 and uses thereof (2020-05-19),
9. 10626176 - Methods of treating conditions with antibodies that bind B7-H4 (2020-04-21),
10. 10570203 - Antibodies to ICOS (2020-02-25),
11. 10023635 - Antibodies to ICOS (2018-07-17),
Company Overview
Jounce Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative immunotherapies for cancer treatment. The company specializes in harnessing the immune system to target and eliminate tumors, utilizing its proprietary Jounce Therapeutics platform to identify and develop novel therapeutic candidates. With a commitment to advancing cancer care, Jounce aims to improve patient outcomes through its research in immune-oncology and related fields.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Jounce Therapeutics, Inc. USPTO Patent Assignee Logo
11 Patents

#216 in Cambridge, MA

#1,662 in Massachusetts

#27,540 in US

#51,831 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Jounce Therapeutics, Inc.

Forward Citations = 17

26 inventors:

goldMedal Stephen Sazinsky (6 out of 6 patents)

silverMedal Sriram Sathyanarayanan (4 out of 10 patents)

bronzeMedal George Robert Mabry, Iii (3 out of 3 patents)

4.  Kutlu Goksu Elpek (3 out of 6 patents)

5.  Jennifer S Michaelson (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jounce Therapeutics, Inc.. Retrieved from https://idiyas.com/company/jounce-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…